AME Logo
DW

David Wohl

MD

UNC School of Medicine, United States

Biography

Dr. Wohl is a Professor of Medicine in the Division of Infectious Diseases at the University of North Carolina (UNC). He is co-Principal Investigator of the Global UNC Infectious Diseases Clinical Research Unit and Site Leader of its Chapel Hill research site.

Dr. Wohl is a clinical scientist with a focus on emergent infectious diseases. He has spent over 20 years leading research into the prevention and treatment of HIV and served two terms as a member of the US Department of Health and Human Services (DHHS) Antiretroviral Guidelines Panel.

Since 2014, he has been working continuously in Liberia, West Africa, conducting research with Ebola survivors to learn about chronic complications and sexual transmission of this infection and establishing the UNC Project Liberia research platform at two locations in the country. He and his team have extended this work to examine Lassa fever, a viral hemorrhagic fever endemic in West Africa.

In 2020, he contributed to the UNC clinical and research response to COVID-19. He is medical director of the UNC Chapel Hill drive through testing site as well as two COVID-19 vaccination clinics and the Chapel Hill COVID-19 monoclonal antibody infusion center. He serves as Vice Chair of ACTIV-2, an international trial of promising SARS-CoV-2 therapeutics.

He has an active clinical practice at the UNC Infectious Diseases Clinic.

RELATED COURSES

HIV 24/7 | Improving Metabolic Health in PLWHIV – Taking the Next Step!
HIV
Metabolic Health
60 min
David Wohl, Roger Bedimo, Jen Manne-Goehler, Daniel Lee, Jonathan Schapiro

HIV 24/7 | Improving Metabolic Health in PLWHIV – Taking the Next Step!

This self-paced e-learning program explores the critical role of metabolic health in the long-term care of people living with HIV (PLWHIV). Through expert-led modules, it examines key challenges and strategies to improve outcomes, with a particular focus on the impact of visceral fat accumulation. Participants will learn about its pathological consequences, diagnostic complexities, and available treatment options, while also gaining practical insights into the prevalence of metabolic complications and the use of clinical and laboratory assessments. Designed to be both informative and actionable, the program equips clinicians with the knowledge and tools to take the next step in advancing metabolic health for PLWHIV.

What Will Set You Apart?​

After following this educational series, participants will:

  • Recognize the burden and clinical consequences of excessive visceral fat in people living with HIV
  • Be informed of evidence-based strategies to diagnose and assess visceral fat in clinical practice
  • Identify current therapeutic options and holistic approaches for the management of metabolic health in PLWHIV

Is This Program for You?

This self-learning educational program is aimed at physicians, nurses, pharmacists, and other healthcare professionals caring for people living with HIV.

What Will You Cover in This Module?

  • The diseases burden and pathological consequences of visceral fat in PLWHIV
  • Clinical approach to diagnosing excessive visceral fat in PLWHIV
  • Current therapeutic treatment options for PLWHIV with excessive visceral fat
  • Optimal clinical approach to managing excessive visceral fat in PLWHIV

Program Director: Jonathan Schapiro